FDA approves transdermal patch for migraine
The Food and Drug Administration has approved sumatriptan iontophoretic transdermal system or acute treatment of adults who have migraine with or without aura. The single-use, battery-powered patch offers relief of migraine-related nausea as well as migraine headache pain. Of 16 million U.S. adults diagnosed and treated with migraine, 8 million have MRN and typically avoid use of oral medications.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063